FdaApplication
NDA 022517
Identifiers
- fda_app_no: NDA022517
Properties
| Property | Value |
|---|---|
| applicant_name | FERRING PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2018-06-21 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NOCDURNA | DESMOPRESSIN ACETATE | 0.0277MG | TABLET;SUBLINGUAL |
| NOCDURNA | DESMOPRESSIN ACETATE | 0.0553MG | TABLET;SUBLINGUAL |
2 products